During the past two decades, glycopeptide-resistant enterococci, in particular *Enterococcus faecium*, have become increasingly widespread throughout the world and have been identified as multi-resistant opportunistic pathogens in hospitals and in the environment (e.g., in foods and animals) ([@B15], [@B18]). Since the first detection of vancomycin resistance in *E. faecium* in 1988, nine operons that confer resistance to glycopeptides have been distinguished based on the sequence of the structure for the resistance ligase ([@B16], [@B23], [@B15]). These operons are classified according to the characteristics of the ligase gene, which can encode either a D-alanyl-D-lactate ligase or a D-alanyl-D-serine ligase. Genes that encode D-alanyl-D-lactate ligases include the *vanA*, *vanB*, *vanD* and *vanM* genes and those that encode D-alanyl-D-serine ligases include the *vanC* ~1~, *vanC* ~*2*~, *vanC* ~*3*~, *vanE*, *vanG*, *vanL* and *vanN* genes ([@B2], [@B4], [@B15], [@B18]). Resistance types can be acquired except for *vanC*-type resistance, which is thought to be intrinsic to *Enterococcus gallinarum*and *Enterococcus casseliflavus*. The vanC~1~ cluster is composed of five genes*: vanC* ~*1*~, *vanXYc*, *vanTc*, *vanRc*and *vanSc*. Three of these genes are involved in inducing resistance according to the following mechanism: *vanC* ~*1*~ encodes a ligase that synthesises the dipeptide D-Ala-D-Ser, which is added to the UDP-MurNAc-tripeptide; *vanXYc* encodes a D,D-dipeptidase-carboxypeptidase that hydrolyses D-Ala-D-Ala and removes D-Ala from UDP-MurNAc-pentapeptide; *vanT* encodes a membrane-bound serine racemase that provides D-Ser to the synthetic pathway ([@B1]). The *vanC* ~*1*~ gene is thought to occur only in *E. gallinarum* and should therefore be useful for species identification ([@B21]). Furthermore, this gene is chromosomally located and has not been found in *E. faecium* until now. Since the *vanC* ~*1*~ gene was first identified in vancomycin-susceptible *Enterococcus faecalis* strains isolated from pig manure samples in Germany, *vanC* ~*1*~-type *E. faecalis* of animal origin has been reported in Spain and Brazil. This finding emphasises that the chromosomal location of a gene in intrinsically resistant strains does not necessarily prevent gene transfer to another species, which is in contrast to traditional views ([@B22], de [@B6], de [@B7]). So far, there has been one report of the genetic location of the *vanC* ~*1*~ gene isolated from cloacal swabs of broilers and this gene was detected on plasmid (de [@B7]). We also identified *vanC* ~*1*~-type *E. faecium* strain isolated from a blood culture.

In this study,*E. faecium* TJ4031 was susceptible to both vancomycin and teicoplanin, but harboured the *vanC* ~*1*~ resistance gene. We also presented evidence showing that the *vanC* ~*1*~ gene cluster was incomplete; the *vanC* ~*1*~ and *vanXYc* genes were not expressed. Additionally, the resistance gene in this clinical isolate was located on the chromosome.

MATERIALS AND METHODS
=====================

*Strains* - *E. faecium*TJ4031 was isolated in 2012 from a blood culture from an outpatient in our hospital. This isolate was initially identified by Gram staining and biochemical reaction as previously described ([@B8]). Furthermore, the Vitek2-Compact system (bioMérieux, France) was used and *Enterococcus*-specific polymerase chain reaction (PCR) was performed ([@B12]). This strain was also distinguished from *E. gallinarum* by determining the *E. gallinarum* *sod*gene using the species-specific Egaspe primer set. The primers used are listed as follows: Egaspe F, GAACCAACAGGAGCCATCA; Egaspe R, ACCAAGCCCAGCCAGAAC ([@B20]). TJ430, which was confirmed as *E. gallinarum* isolated from a clinical specimen and *E. faecalis* ATCC29212, was used as positive and negative controls, respectively, for the detection and expression analysis of the *vanC* ~*1*~, *vanXYc* and *vanTc*genes. TJ430 was also used as control strain to analyse the location of the *vanC* ~*1*~ gene. *Salmonella* H9812 was used as a marker for pulsed-field gel electrophoresis (PFGE).

*Antibiotic susceptibility testing* - Minimum inhibitory concentrations (MICs) were determined according to a standard agar dilution procedure, as recommended by the Clinical and Laboratory Standards Institute (CLSI 2012). *E. faecalis* ATCC29212 was used as a control strain.

*Molecular typing and genetic techniques* - TJ4031 was typed by subjecting genomic DNA to PFGE using the CHEF II Mapper system (Bio-Rad, France) ([@B15]). Total DNA was digested with *SmaІ* and then electrophoresed (6 V/cm, 17 h, pulse times of 1-17 s at 14ºC) on an agarose gel. Total DNA from the H9812 marker was digested with *XbaI*. The plasmid size and content of the TJ4031 isolate were determined using the S1 nuclease method ([@B10]). The location of the *vanC* ~*1*~ gene was determined using southern hybridisation. A *vanC* ~*1*~ probe was constructed by labelling an internal amplification product of the *vanC* ~*1*~ gene from TJ4031 with digoxigenin according to the manufacturer's protocol (Roche, Switzerland). The primers used to amplify the product are listed as follows: *vanC* ~*1*~ F, 5'-ATGGCTGTATCCAAGGACTG-3'; *vanC* ~*1*~ R, 5'-AGGCAATGGTGCTGGGAC-3'.

The *E. faecium*TJ4031 isolate was subjected to multilocus sequence typing (MLST) analysis ([@B25], [@B11]). The alleles and sequence type (ST) were determined using the MLST database (efaecium.mlst.net). The new ST identified in this study has been deposited in the database.

*PCR* - *E. faecium* isolates were species identified with PCR using *Enterococcus*-specific primers combined with species-specific primers for the *E. gallinarum sod*gene ([@B20], [@B12]). *E. faecium* TJ4031 was also evaluated to determine the presence of *vanA*,*vanB*,*vanC* ~*1*~,*vanC* ~*2/3*~and *vanXYc*,*vanTc*([@B19], [@B22]).

*Sequence analysis* - The band from the *vanC* ~*1*~-positive strain was excised from the gel and then sequenced. Sequence similarity was compared using the NCBI Basic Local Alignment Search Tool database (ncbi.nlm.nih.gov).

*RNA extraction and reverse* *transcription-PCR (RT-PCR)*- Total RNA from strain TJ4031 grown in brain-heart-yeast extract broth at 37ºC to an absorbance at 600 nm of 0.8 was isolated using an RNeasy Mini Kit (Qiagen, Germany). Transcripts were obtained using a RevertAid First Strand cDNA system kit (Fermentas) according to the manufacturer's instructions. Real-time RT-PCR was conducted in a final volume of 20 µL containing 10 µL SYBR Mix (NovoGene), 0.5 µM primers and 3 µL template cDNA. The reaction was performed using a Light Cycler 480 (Roche) under the following conditions: initial denaturation at 95ºC for 7 min and 40 cycles of denaturation at 95ºC for 10 s, annealing at 57ºC for 15 s, elongation at 72ºC for 30 s and cooling at 40ºC for 30 s. The primers used in this procedure are as follows: vanrtC1 F, ATTGGTGCTTGTGATGCG; vanrtC~1~ R, CGGGAGTGCCCAGTAAA; vanXYc F, GCAAAACAATGGGAACGACT; vanXYc R, ATCTCGAAAATGAGGGCAGA. Non-reverse-transcribed PCR controls were used to indicate the absence of genomic DNA contamination. ATCC29212 and TJ430 were used as negative and positive control strains, respectively.

RESULTS
=======

*Characterisation of E. faecium TJ4031* - The clinical isolate TJ4031, which was isolated from a blood culture, was identified as *E. faecium* using conventional tests and the Vitek2-Compact system; species identity was confirmed by PCR. *E. gallinarum* was excluded as a possibility by a negative result in an *E. gallinarum* species-specific PCR. TJ4031 was susceptible to vancomycin (MIC = 2 µg/mL) and teicoplanin (MIC = 1 µg/mL). TJ4031 was also susceptible to chloramphenicol, linezolid, ciprofloxacin, levofloxacin and fosfomycin. By comparison, this strain was resistant to penicillin, rifampicin, erythromycin and nitrofurantoin. TJ4031 was positive for the *vanC* ~*1*~ and *vanXYc* genes, but negative for the *vanTc* gene. The *vanC* ~*1*~ gene sequence was deposited in GenBank (accession KF849246).

*Identification of gene expression by real-time RT-PCR* - RT-PCR assays failed to detect the corresponding *vanC* ~*1*~ and *vanXYc* gene transcripts in the *vanC* ~*1*~ gene positive *E. faecium* TJ4031 strain. The positive and negative controls worked as expected.

*Molecular typing* - The *E. faecium* TJ4031 isolate was categorised as a new ST according to MLST analysis and designated as ST837 (AtpA, 52; Ddl, 5; Gdh, 1; PurK, 1; Gyd, 1; PstS, 1; Adk, 3). This new ST showed the greatest similarity to the reported MLST type ST547 (AtpA, 15; Ddl, 5; Gdh, 1; PurK, 1; Gyd, 1; PstS, 1; Adk, 3) based on the information from the database (MLST database URE) (efaecium.mlst.net/). ST837 was a single-*locus* variant of ST547. Neither ST547 nor ST837 belong to the well-characterised clonal complex (CC) 17, which is found in a hospital-adapted and epidemic *E. faecium* strain cluster.

*Genetic location of vanC* ~*1*~ *gene in E. faecium TJ4031* - Figure shows the restriction endonuclease pattern of the *vanC* ~*1*~ genotype in the *E. faecium* TJ4031 strain after PFGE with *SmaI*was performed. The location of the *vanC* ~*1*~ gene was determined using southern blot hybridisation with a *vanC* ~*1*~ probe. PFGE hybridisation analysis results showed that the *vanC* ~*1*~ probe hybridised to the chromosomal DNA band and that the size of the macrorestriction fragment was between 78.2-104.5 Kbp ([Figure](#f01){ref-type="fig"}). However, S1-PFGE analysis results showed that a plasmid was absent in the TJ4031 isolate (data not shown). The results indicated that the *vanC* ~*1*~ gene was located in the chromosome.

A: pulsed-field gel electrophoresis of *SmaI* digested genomic DNA from TJ4031 and TJ430 strains. The first lane is H9812 digested with *XbaI* as marker with relevant sizes indicated to the gel; B: hybridisation of southern transfer of DNA in left panel using an internal fragment of *vanC1* as a probe. The result showed that the probe hybridised to the chromosome and the size was between 78.2-104.5 Kbp.

DISCUSSION
==========

The*vanC*intrinsic resistance genotype is associated with several enterococcal species, including *E. gallina- rum*(*vanC* ~*1*~),*E. casseliflavus*(*vanC* ~*2*~) and*E. flavescens*(*vanC* ~*3*~). These *vanC* operons are chromosome associated and testing *E. faecium* or other *Enterococcus* species for the presence of *vanC* ~*1*~ is considered unnecessary because this gene is thought to be species-specific for *E. gallinarum*([@B17], [@B22]). However, the *vanC* ~*1*~ gene has also been detected in *E. faecalis* strains isolated from pig manure samples (Germany), sheep bulk tank milk samples (Spain) and cloacal swabs of broilers (Brazil).

In our study, expected biochemical reactions were observed in the*vanC* ~*1*~ genotype-positive *E. faeciu*m TJ4031.*E. faecium* was also analysed using the Vitek2-Compact system. Moreover, the *Enterococcus* and*E. gallinarum*-specific PCR results of this study are consistent with those of other bacteriological studies ([@B19], [@B1], [@B25], de [@B7]). Our study failed to detect the corresponding *vanC* ~*1*~ and *vanXYc*genes in a *vanC* ~*1*~ genotype-positive strain with real-time RT-PCR assays and similar results have been previously reported ([@B22], de [@B7]). This result could be attributed to a non-functional *vanC* ~*1*~ gene cluster that has been transferred from a bacterial community to our strain or to a failed recombination event that inserted a non-functional gene and removed beneficial DNA ([@B14], de [@B7]). In a previous study, the *vanC* ~*1*~ gene was found on a plasmid (de [@B7]). However, our study showed that the*vanC* ~*1*~ genotype of the *E. faecium* TJ4031 isolate contained no plasmid; this procedure was repeated in triplicate to verify our initial findings. The possible explanation is that megaplasmids, which cannot be detected with current techniques, or bacteria without plasmids may be present. Furthermore, the *vanC* ~*1*~ gene was successfully hybridised to the chromosome band using southern blot, showing that this gene was located in this chromosome.

*E. faecium* TJ4031 may have acquired the *vanC* ~*1*~ gene *via* a horizontal gene transfer from a natural carrier (*E. gallinarum)* or from a carrier of animal origin (*E. faecalis)*([@B22], de [@B6], de [@B7]) because strains from human-adapted CCs that cause enterococcal infection may be recovered from farm and companion animals and strains from CCs commonly found among animals have also been isolated from humans. Furthermore, other studies have revealed several cases of animal-human transmission of vancomycin-resistant enterococci, resulting in frequent infections of healthy humans that closely interact with animals ([@B5], [@B11], [@B9], [@B24], [@B13]).

This study was the first to identify the *vanC* ~*1*~ gene in a vancomycin-susceptible *E. faecium* strain isolated from the blood culture of a patient in China. Our result is important because the *vanC* ~*1*~ gene is often used to identify *E. gallinarum*; without this gene, species may be erroneously identified. This result also emphasises that the chromosomal location of a gene in an intrinsically resistant strain does not necessarily prevent transfer to other species, thereby contributing to species diversity. Furthermore, the *vanC* ~*1*~-type vancomycin resistance gene was encoded on the chromosome. Our data indicate that *vanC* ~*1*~-type *E. faecium* strains could be detected in humans. Even if the strain was phenotypically susceptible to vancomycin, the fact that *E. faeciu*m are able to naturally acquire*vanC* ~*1*~ from the bacterial community is a cause for concern because the possibility that complete gene clusters and functional genes will be transferred and expressed cannot be ruled out. This study underlines that *E. faecium* are very potent resistance gene collectors and possibly donors ([@B22]). We should always monitor enterococci in not only human clinical isolates, but also in the commensals from diverse habitats.
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